SELEXON
"SELEXON" is a word mark owned by Aletira Therapeutics, Inc., filed at the USPTO on November 26, 2025. It has been allowed and covers classes 5 and 42.
- Status
- Allowed
- Since July 14, 2026
- Filed
- November 26, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99518932
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns SELEXON
The owner and representative on file with the office.
Owner
Aletira Therapeutics, Inc.
Baltimore, United States
Representative
Michael Graif
Brown Rudnick LLP
What the mark covers
The products and services SELEXON is filed for, grouped by Nice class.
Gene therapy products, namely, components of cells for medical use that restrict expression to specific cells through the use of alternative splicing
Gene therapy research in the field of restricting cell expression to specific cells through the use of alternative splicing
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of examiner's amendment/priority action e-mailed
- Examiner's amendment/priority action e-mailed
6 earlier steps on the official record.
About SELEXON
Who owns the trademark "SELEXON"?
The USPTO trademark "SELEXON" (application 99518932) is owned by Aletira Therapeutics, Inc.
What is the status of "SELEXON"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull SELEXON and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b67-fbf1-7320-abff-0a65f5d42408
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b67-fbf1-7320-abff-0a65f5d42408",
"object": "trademark",
"mark_text": "SELEXON",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99518932",
"filing_date": "2025-11-26",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Aletira Therapeutics, Inc.",
"entity_id": null
}
]
}